Immunogenic composition for paratuberculosis
US12186382B2 · kind B2 · utility
0Cited by
7References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 10, 2019 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Feb 7, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/5256
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A vaccine comprising a polypeptide comprising an amino acid sequence of at least 9 contiguous amino acids from the N-terminal region of MAP P900, or a polynucleotide encoding said polypeptide, for use in a method of treating or preventing MAP infection or a condition or symptom associated with MAP infection in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.